Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1 Locally Advanced or Metastatic Unresectable Urothelial Cancer 1

Interventions

Gemcitabine 11 Magnetic Resonance Spectroscopy 10 Specimen Handling 8 Cisplatin 7 pembrolizumab 6 Radiation 5 Mitomycin 4 Fluorouracil 4 Cystoscopy 4 enfortumab vedotin 3 durvalumab 3 dehydroftorafur 3 avelumab 3 Transurethral Resection of Bladder 3 Radiotherapy 3 Platinum 3 Nivolumab 3 Mitozytrex 3 Cystectomy 3 1,2-diaminocyclohexaneplatinum II citrate 3 ulixertinib 2 tremelimumab 2 erdafitinib 2 atezolizumab 2 Paclitaxel 2 Immunoglobulin G 2 Docetaxel 2 Disulfides 2 Carboplatin 2 Biopsy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × vinflunine × 30 days × Clear all

NCT07419295 2026-05-29

TroFuse-031

Merck Sharp & Dohme LLC

Phase 3 Recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡